
    
      The objective of this prospective, single-center, open label, feasibility test is to assess
      the safety and efficacy of Mitral Loop Cerclage Annuloplasty with CSTV protective device in
      treating functional mitral regurgitation (FMR) associated with heart failure.
    
  